natgillin/translations-raw huggingface dataset:
Selv om den omtvistede forordning fremtræder som en almengyldig foranstaltning i EF-traktatens artikel 189's forstand (nu artikel 249 EF), kunne det ikke udelukkes, at den kunne berøre appellanten umiddelbart og individuelt, da virksomheden er den eneste producent af virginiamycin i verden, og da virksomheden i denne egenskab er videnskabeligt og finansielt involveret i et program for overvågning af mikrobiel resistens hos dyr, der har fået indgivet antibiotika, et program, som med hensyn til resultaternes pålidelighed kan blive berørt af den omtvistede forordning.
Although the contested regulation took the form of a measure having general application within the meaning of Article 189 of the EC Treaty (now Article 249 EC), it might be of direct and individual concern to Pfizer, since it was the sole manufacturer of virginiamycin in the world and was, in that capacity, scientifically and financially involved in the surveillance programme concerning microbial resistance in animals which have received antibiotics, the reliability of which in terms of its results might be affected by the contested regulation.
17 Hvad dernæst angår spørgsmålet om fumus boni juris fastslog Rettens præsident i den anfægtede kendelses præmis 131, 132 og 133, at det anbringende, hvormed appellanten nærmere bestemt gjorde gældende, at forsigtighedsprincippet var
17 On the question of a prima facie case, the President of the Court of First Instance considered, in paragraphs 131 to 133 of the contested order, that Pfizer's plea alleging, in essence, that the precautionary principle had been contravened could
18 Rettens præsident undersøgte derefter i den anfægtede kendelses præmis 134181, om der i forbindelse med begæringen forelå den grad af uopsættelighed, der kræves, for at den begærede foranstaltning kunne fastsættes, og om interesseafvejningen faldt ud til appellantens fordel.
18 The President of the Court of First Instance went on to consider, at paragraphs 134 to 181 of the contested order, whether the application had the degree of urgency required before the measure requested could be ordered and whether the balancing of the interests at stake operated in the applicant's favour.
19 Herom anførte Rettens præsident i den anfægtede kendelses præmis 136, at det eneste tab, der skal tages i betragtning i forbindelse med undersøgelsen af uopsættelighedsbetingelsen, var det tab, som kunne tænkes påført den begærende parts interesser.
19 In that connection the President of the Court of First Instance held, at paragraph 136 of the contested order, that the only damage that could be taken into account in his examination of the criterion of urgency was that which might be caused to the interests of the party seeking the interim relief.
Vedrørende spørgsmålet om en økonomisk skade undersøgte Rettens præsident på den ene side, om selve appellantens eksistens kunne blive bragt i fare, hvorved Rettens præsident særligt tog hensyn til virkningerne af anvendelsen af den omtvistede forordning for fabrikken i Rixensart og for appellantens økonomiske levedygtighed, og på den anden side, om appellantens markedsandele kunne blive ændret uopretteligt.
20 With regard to damage of a purely pecuniary nature, the President of the Court of First Instance examined, first, whether Pfizer's very existence was likely to be endangered, concentrating on the effects of application of the contested regulation on the Rixensart factory and on Pfizer's financial viability and, second, whether its market share was likely to be irremediably affected.
21 Vedrørende fabrikken i Rixensart fastslog Rettens præsident, at det ikke fremgik af oplysningerne i sagen, at ikrafttrædelsen af den omtvistede forordning uundgåeligt ville føre til, at fabrikken inden for kort tid måtte lukke, i betragtning af omfanget af salget af virginiamycin, i mængde såvel som værdi, på markederne uden for Vesteuropa.
21 As far as the Rixensart factory was concerned, the President of the Court of First Instance found that it could not be concluded, on the evidence before him, that the entry into force of the contested regulation would inevitably result in the rapid closure of the plant in view of the high volume and value of sales of virginiamycin on markets other than the West European market.
22 Ifølge Rettens præsident er det ikke påvist, at de af appellanten påtænkte afskedigelser, som vil berøre 18% af de ansatte, vil føre til lukning af fabrikken i Rixensart, og heller ikke, at salgsafdelingerne ikke ville være i stand til at
22 In his view, it had not been shown that the reduction in employment envisaged by Pfizer, concerning 18% of the Rixensart staff, was likely to lead to the closure of
Rettens præsident afviste endvidere, at der kunne tages hensyn til situationen for underleverandørerne, hvis forbindelser med fabrikken i Rixensart i øvrigt ikke var blevet nærmere oplyst.
The President of the Court of First Instance also declined to take into account the situation of subcontractors whose precise relationship to the Rixensart factory had not, moreover, been established.
Vedrørende appellantens økonomiske levedygtighed bemærkede Rettens præsident, at der i prognoserne forventedes en væsentlig nedgang i salget af virginiamycin efter forbuddet mod markedsføring i Det Europæiske Fællesskab.
As to Pfizer's financial viability, the President of the Court of First Instance noted that forecasts indicated an appreciable fall in sales of virginiamycin following the ban on marketing in the European Community.
I betragtning af den del, som denne virksomhed udgjorde inden for hele Pfizer koncernen, således som denne kunne bedømmes, fandt Rettens præsident imidlertid, at den økonomiske skade ikke var af et sådant omfang, at appellanten ikke vil kunne fortsætte sin virksomhed, indtil der er truffet afgørelse i hovedsagen.
However, in view of the proportion of the Pfizer group's total business represented by that activity, as far as it could be assessed, he did not consider that the financial harm that Pfizer would suffer would prevent it from continuing to pursue its activities pending judgment in the main action.
Rettens præsident undersøgte også virkningerne af forbuddet for udviklingen i appellantens markedsandele.
The President of the Court of First Instance also examined the effects that the ban would have on Pfizer's market share.
Ifølge præsidenten kunne der ikke tages hensyn til nedgangen i salget i lande, der ikke er medlemmer af Den Europæiske Union, fordi nedgangen ikke var en direkte følge af den omtvistede forordning.
In his view, the decrease in sales in countries which are not Member States of the Union could not be taken into account, since it was not the direct consequence of the contested regulation.
Vedrørende markedsandelene i Det Europæiske Fællesskab fremgik det ikke af oplysningerne i sagen, at de ville blive uopretteligt ramt.
As far as market share in the European Community was concerned, there was nothing in the documents before the Court to show that it would be irremediably compromised.
I den anfægtede kendelses præmis 165 konkluderede Rettens præsident, at sagsøgeren ikke havde kunnet bevise, at virksomheden ville lide en alvorlig og uoprettelig skade, hvis gennemførelsen af den anfægtede forordning ikke blev udsat, og Rettens præsident fastslog derefter, at interesseafvejningen under alle omstændigheder talte for at opretholde den anfægtede forordning, idet en skade på erhvervsmæssig og samfundsmæssig interesse som den, sagsøgeren og de til støtte for sagsøgeren intervenerende parter ville blive påført, ikke kunne veje
Having concluded, in paragraph 165 of the contested order, that the applicant had not succeeded in showing that it would suffer serious and irreparable damage if operation of the contested regulation were not suspended, the President of the Court of First Instance considered that, in any event, the balancing of the interests at stake favoured the maintenance of the contested regulation, since damage to the commercial and social interests of the kind which the applicant and the parties supporting it would sustain could not outweigh the damage to public
Rettens præsident fastslog herved, at de i sagen fremlagte dokumenter bekræftede, at bakterier, som hos dyr er resistente over for virginiamycin, kan overføres til mennesker.
The President of the Court of First Instance found that the documents before him confirmed that bacteria resistant to virginiamycin in animals were transmissible to humans.
Præsidenten anså det følgelig ikke for umuligt, at brugen af virginiamycin i foderstoffer kan øge den antimikrobielle resistens i humanmedicin, hvilket kan få potentielt meget alvorlige følger for folkesundheden.
It followed, in his view, that the risk of increased antimicrobial resistance in human medicine on account of the use of virginiamycin in animal feed could not be ruled out, and the potential consequences for public health would be very serious.
På denne baggrund fandt Rettens præsident — uden at foregribe Rettens undersøgelse af vurderingen af omfanget af den risiko, som de berørte institutioner skal påvise, når de vedtager en sikkerhedsforanstaltning — at den blotte eksistens af den således påviste risiko berettiger til, at der ved interesseafvejningen tages hensyn til beskyttelsen af menneskers sundhed.
In the circumstances, the President considered that, without prejudging the examination by the Court of First Instance of the assessment of the extent of the risk which must be established by the institutions concerned when adopting a precautionary measure, the mere existence of the risk so identified was enough in itself to justify taking into account, in the balancing of interests, the protection of human health.
Tre af appelanbringenderne såvel som det yderligere anbringende, der er fremført af Hedwig Kerckhove og Paul Lambert, vedrører Rettens præsidents bedømmelse af uopsætteligheden.
Three of the grounds of appeal, together with the additional plea put forward by H. Kerckhove and P. Lambert, concern the assessment by the President of the Court of First Instance of the urgency of the matter.
Det sidste anbringende, som appellanten har fremført, vedrører interesseafvejningen, således som den fremgår af den anfægtede kendelse.
The last ground of appeal concerns the balancing of interests undertaken in the contested order.
Fejlagtig bestemmelse af tabet, fordi der blev taget hensyn til situationen for appellantens moderselskab
Wrongful determination of harm because the situation of Pfizer's parent company was taken into account
PFIZER ANIMAL HEALTH MOD RÅDET fremgår af den anfægtede kendelse, er forkert, fordi der ikke alene er taget hensyn til virksomhedens forhold, men også til situationen for dens moderselskab.
PFIZER ANIMAL HEALTH V COUNCIL wrongful, in that account was taken not only of its situation, but also of that of its parent company.
30 Ifølge appellanten er den retspraksis, der er nævnt i præmis 155 i den anfægtede kendelse, irrelevant for den foreliggende sag.
30 According to the appellant, the caselaw cited in paragraph 155 of the contested order is irrelevant to this case.
Pfizer-koncernens finansielle midler kan således ikke yde erstatning for, at appellanten mister ansatte, eller at dens fabrik lukkes, hvilket er følgerne af den omtvistede forordning for appellantens egen virksomhed. Selv om Pfizer-koncernens eksistens ikke er truet, udelukker dette ikke, at der foreligger et alvorligt og uopretteligt tab for appellanten.
The financial resources of the Pfizer group cannot remedy the consequences of the contested regulation for its own business, which are that its employees will leave and its factory will close.
Efter dennes opfattelse bør en lille virksomhed, der indgår i en stor koncern, kunne kræve anvendelse af foreløbige forholdsregler, hvis den udsættes for et alvorligt og uopretteligt tab, navnlig i form af tab af arbejdspladser.
It considers that a small company in a large group should be eligible for the benefit of interim measures if faced with serious and irreparable harm, notably job losses.
De ansattes legitime interesse i deres ansættelse må heller ikke lades ude af betragtning, blot fordi de arbejder for et selskab, der indgår i en større koncern.
Moreover, employees should not be deprived of their legitimate interest in their jobs simply because they work for a company belonging to a large group.
Den af Rettens præsident indtagne holdning vil medføre, at selskaber, der indgår i en stor koncern, fratages deres ret til en effektiv retsbeskyttelse.
The test applied by the President of the Court of First Instance amounts ţo denying effective judicial protection to companies which are part of a substantial corporate group.
31 Kommissionen og den danske regering har anført, at den økonomiske stilling for den koncern, som appellanten indgår i, blot er taget i betragtning som en blandt andre omstændigheder i Rettens præsidents bedømmelse.
31 For their part, the Commission and the Danish Government state that the financial situation of the group to which the appellant belongs was only one factor of many taken into account by the President of the Court of First Instance.
32 Rådet, Kommissionen og den finske regering har endvidere gjort gældende, at den retspraksis, der er anført i præmis 155 i den anfægtede kendelse, er helt relevant, og bekræfter, at der med rette er taget hensyn til situationen for appellantens moderselskab.
32 The Council, the Commission and the Finnish Government also contend that the caselaw cited in paragraph 155 of the contested order is entirely relevant and confirm that it was wholly justifiable to take into account the situation of the appellant's parent company.
Indsigelsen om, at dette kriterium fører til en diskrimination over for de store koncerner, er efter Kommissionens opfattelse meningsløs.
The Commission considers the complaint that that criterion would lead to discrimination against large groups to be wholly misconceived.
For at bedømme, om en foranstaltning vil have alvorlige og uoprettelige økonomiske virkninger for en sagsøger, er det ifølge Kommissionen åbenbart nødvendigt at tage hensyn til dennes økonomiske situation, som naturligvis ikke kan bedømmes uden at tage hensyn til den økonomiske situation for den koncern, sagsøgeren indgår i.
In its view, when it comes to deciding whether a measure will have serious and irreparable financial consequences for an applicant, it is obviously necessary to have regard to the latter's financial situation, which clearly cannot be assessed without taking account of the financial situation of the group to which it belongs.
Under henvisning til appellantens forbindelser med virksomhedens moderselskab, har Rådet anført, at den har adgang til de meget store ressourcer i
For its part the Council, emphasising the appellant's links with its parent
Fejlagtig bestemmelse af tabet, når henses til Domstolens praksis om uopretteligt tab af markedsandele
Wrongful determination of damage with regard to the caselaw of the Court of Justice on irretrievable loss of market share
Med det andet anbringende gør appellanten gældende, at fællesskabsretten er blevet tilsidesat, fordi Rettens præsident med urette konkluderede, at der ikke forelå et uopretteligt tab af markedsandele.
The second ground of appeal alleges an infringement of Community law by reason of the fact that the President of the Court of First Instance wrongly concluded that there would be no irretrievable loss of market share.
I nærværende sag, hvor det pågældende produkt er totalt forbudt i de femten medlemsstater, er et sådant tab ikke antaget at foreligge, selv om det i tidligere praksis er anset for et uopretteligt tab, at der forelå et langt mindre tab blot i nogle få medlemsstater.
Such loss was not acknowledged in this case, in which the product concerned is wholly banned in the 15 Member States, whereas a much lower level of loss in a few Member States has previously been regarded as irreparable damage.
Appellanten henviser i denne forbindelse til kendelse afsagt af Rettens præsident den 3. juni 1996 i sagen Bayer mod Kommissionen (sag T-41/96 R, Sml. II, s. 381), hvori det blev fastslået, at risikoen for, at et datterselskab af sagsøgeren i et tredjeland kunne miste markedsandele, hvilket eventuelt kunne føre til afskedigelser, var en relevant omstændighed under en sag om foreløbige forholdsregler.
The appellant refers in this connection to the order of the President of the Court of First Instance in Case T-41/96 R Bayer v Commission [1996] ECR 11-381, in which it was concluded that the risk that a Bayer subsidiary in a different country might lose market share, resulting in the possible dismissal of employees there, was a relevant factor in proceedings for interim relief.
Appellanten henviser endvidere til kendelse af 8. april 1987, Pfizer International mod Kommissionen (sag 65/87 R, Sml. s. 1691), hvori det blev anerkendt, at en stærk nedgang i salget, navnlig i tre medlemsstater, forårsagede et alvorligt og uopretteligt økonomisk tab, da de markedsandele, der var gået tabt til konkurrenterne, mens sagsøgeren havde været fraværende fra markedet i elleve måneder, i praksis ikke kunne vindes tilbage senere.
The appellant also refers to the order of 8 April 1987 in Case 65/87 R Pfizer International v Commission [1987] ECR 1691, in which it was acknowledged that a sharp decrease in sales, particularly in three Member States, had caused serious financial loss and that this damage was irreparable since the market shares lost to competitors during 11 months' absence from the market could not be subsequently regained in practice.
Ifølge appellanten er virksomhedens situation i den foreliggende sag endnu værre, når henses til varigheden af udelukkelsen og den geografiske udstrækning af de pågældende markeder, og den samme retspraksis burde derfor have fundet anvendelse, eller der skulle i det mindste have været givet en tilfredsstillende begrundelse for den manglende anvendelse af denne retspraksis.
According to the appellant, its own situation in this case is even worse in terms of length of exclusion from and geographic extent of the markets concerned and should have led to the same caselaw being applied or at least an adequate statement of reasons for the caselaw not being followed.
Den omstændighed, at der er forskellige faktiske omstændigheder i de to sager, bør alene tages i betragtning i
The different factual circumstances in the two cases was a
PFIZER ANIMAL HEALTH MOD RÅDET forbindelse med interesseafvejningen og ikke i forbindelse med bedømmelsen af uopsætteligheden.
PFIZER ANIMAL HEALTH V COUNCIL factor that should not have been taken into consideration until the balancing of interests stage, rather than when the criterion of urgency was being examined.
Appellanten, som har mindet om, at 31 ansatte vil blive afskediget, hvis den omtvistede forordning ikke udsættes, gør i øvrigt gældende, at virksomhedens angivelige økonomiske evne til at fastholde disse medarbejdere, uden at beskæftige dem, ikke ændrer den kendsgerning, at forordningen har påført virksomheden et alvorligt og uopretteligt tab.
Moreover, pointing out that 31 employees will have to be dismissed if the contested regulation is not suspended, the appellant claims that its supposed financial capacity to keep on staff who have no work to do does not alter the fact that the regulation has caused it serious and irreparable harm.
Ifølge Rådet, Kommissionen og den danske regering kan det andet anbringende ikke realitetsbehandles, da der foreligger en bedømmelse af de faktiske omstændigheder dels ved Rettens præsidents konstatering af, at de pågældende markedsandele kan vindes tilbage, dels ved konstateringen af, at appellanten finansielt er i stand til at bære omkostningerne ved at fastholde 31 ansatte på fabrikken i Rixensart i sin tjeneste.
According to the Council, the Commission and the Danish Government, the findings of the President of the Court of First Instance that the market share concerned could be recovered and that the appellant was financially able to bear the cost of keeping on those 31 employees of the Rixensart factory are findings of fact, so that the second ground of appeal is inadmissible.
Endvidere finder Rådet og Kommissionen såvel som den danske og den finske regering, at appellantens situation i nærværende sag i faktisk henseende er helt forskellig fra situationen for de virksomheder, der var omhandlet dels i den ovennævnte sag Bayer mod Kommissionen — hvori det blev antaget, at der bestod en reel risiko for, at virksomheden i et datterselskab i en koncern kunne være skadet uopretteligt, i det omfang hvor 56% af omsætningen i dette datterselskab var berørt — dels i den ovennævnte sag Pfizer International mod Kommissionen, hvori markedsandelen blev anset for uopretteligt tabt i betragt ning af det pågældende produkts egenskaber.
Furthermore, the Council, the Commission and the Danish and Finnish Governments consider that the appellant's situation in this case is, in point of fact, quite distinct from that of the undertakings involved both in Bayer v Commission, cited above, in which it was held that there was a real risk that the business of a subsidiary could be irreversibly harmed in so far as 56% of the subsidiary's turnover was affected, and in Pfizer International v Commission, cited above, in which loss of market share was held to be irretrievable in view of the characteristics of the product concerned.
Fejlagtig bestemmelse af tabet som følge af manglende hensyntagen til situationen i tredjelande
Wrongful determination of damage because the situation in third countries was not taken into account
Med det tredje anbringende kritiserer appellanten, at Rettens præsident med henblik på at fastslå tabet undlod at tage hensyn til de virkninger, som forbuddet
In the third ground of appeal, the appellant challenges the refusal by the President of the Court of First Instance to take into consideration, when determining
40 Appellanten gør gældende, at de tretten lande, der har ansøgt om at tiltræde Den Europæiske Union, samt de otte lande i Sammenslutningen af Uafhængige Stater (herefter »SNG« ), som Det Europæiske Fællesskab har indgået partnerskabs- og samarbejdsaftaler med, har en retlig forpligtelse til at tilnærme deres nationale lovgivning til de gældende fællesskabsbestemmelser.
40 The appellant states that the 13 countries that are seeking accession to the European Union and the eight countries making up the Commonwealth of Independent States ('CIS') with which the European Community has concluded Partnership and Cooperation Agreements are under a legal obligation to bring their national legislation into line with the acquis communautaire.
41 Den anfægtede kendelse er dermed behæftet med en retlig fejl på dette punkt, for så vidt angår landene, der ansøger om tiltrædelse, og SNG-landene.
41 The contested order is therefore vitiated by an error of law on this point with regard to the countries that are candidates for accession and the CIS countries.
Rettens præsident burde generelt have taget hensyn til den omstændighed, at tredjelandenes vedtagelse af lignende foranstaltninger som den, der er indeholdt i den omtvistede forordning, var en forudsigelig konsekvens af vedtagelsen af denne forordning.
More generally, the President of the Court of First Instance should have taken into account the fact that the adoption by third countries of measures analogous to those contained in the contested regulation was a foreseeable consequence of the adoption of that regulation.
Rådet, Kommissionen og den danske regering finder, at dette anbringende må afvises, da det ikke blev fremført fuldstændigt i første instans.
The Council, the Commission and the Danish Government consider that that ground of appeal is inadmissible because it was not pleaded in full at first instance.